公开(公告)号：US06600056B1

公开(公告)日：2003-07-29

申请号：US09664170

申请日：2000-09-18

申请人： Masatsugu Mikawa ,  Shin-ichi Uchida

发明人： Masatsugu Mikawa ,  Shin-ichi Uchida

IPC分类号： C07D30110

CPC分类号： B01J21/12 ,  B01J23/66 ,  C07D301/10 ,  C07D303/04

摘要： It provide a catalyst for the production of epoxides by a vapor-phase oxidation of an unsaturated hydrocarbon having a chain length of 4-20 carbon atoms and containing no allylic hydrogen atom, characterized by having a catalytic component containing silver and at least one element selected from the group consisting of alkali metals and thallium deposited onto a carrier obtained by mixing &agr;-alumina having a sodium content in the range of 1-70 mmol (as reduced to Na) per kg of &agr;-alumina with an aluminium compound, a silicon compound, and a sodium compound and calcining the resultant mixture, the carrier having a silicon content (as reduced to SiO2) in the range of 0.3 -11.5 mass % based on the mass of the carrier and a sodium content (as reduced to Na2O) in the range of 0.11-2.5 mass % based on the mass of the carrier.

摘要翻译： 它提供了一种催化剂，用于通过气相氧化具有4-20个碳原子的链长度并且不含烯丙基氢原子的不饱和烃的气相氧化来生产环氧化物，其特征在于具有含有银的催化组分和至少一种元素选择 从由碱金属和铊组成的组中沉积到载体上，所述载体通过将钠盐含量为1-70mmol（还原成Na）/α-羟基铝与铝化合物的α-氧化铝混合而获得，硅 化合物和钠化合物，并煅烧所得混合物，载体的硅含量（还原为SiO 2）为0.3-11.5质量％，基于载体的质量和钠含量（还原为Na 2 O） 相对于载体的质量为0.11〜2.5质量％。

公开(公告)号：US20110105486A1

公开(公告)日：2011-05-05

申请号：US12960937

申请日：2010-12-06

申请人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

发明人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

IPC分类号： A61K31/541 ,  C07D277/38 ,  C07D417/14 ,  C07D401/14 ,  C07D213/89 ,  C07D413/14 ,  C07D279/12 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/454 ,  A61K31/5377 ,  A61P25/28 ,  A61P25/00 ,  A61P3/10 ,  A61P25/12 ,  A61P25/24

CPC分类号： C07D417/06 ,  A61K31/427 ,  A61K31/438 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/454 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/497 ,  A61K31/4985 ,  A61K31/501 ,  A61K31/506 ,  A61K31/5383 ,  A61K31/541 ,  A61K31/542 ,  A61K31/551 ,  A61K31/553 ,  A61K31/695 ,  C07D417/04 ,  C07D417/14 ,  C07D491/048 ,  C07D491/10 ,  C07D498/04 ,  C07D513/04

摘要： Wherein n is an integer of from 0 to 3; R1A is a 5-membered aromatic heterocyclic group containing at least one oxygen atom; R2A is —COR8 (wherein R8 is aryl); R3A is hydrogen or lower alkyl; and R12 represents cycloalkyl, aryl, aralkyl, alicyclic heterocyclic group, aromatic heterocyclic group, alicyclic hetocyclic-alkyl, or aromatic heterocyclic-alkyl, and R1A, R2A, R3A and R12 are individually optionally substituted.

摘要翻译： 其中n为0至3的整数; R1A是含有至少一个氧原子的5元芳族杂环基; R2A是-COR8（其中R8是芳基）; R3A是氢或低级烷基; R 12表示环烷基，芳基，芳烷基，脂环族杂环基，芳香族杂环基，脂环族环状烷基或芳香族杂环烷基，R1A，R2A，R3A，R12分别任意取代。

公开(公告)号：US20100256361A1

公开(公告)日：2010-10-07

申请号：US12766986

申请日：2010-04-26

申请人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

发明人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

IPC分类号： C07D417/14 ,  C07D413/14 ,  C07D498/04

CPC分类号： C07D417/06 ,  A61K31/427 ,  A61K31/438 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/454 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/497 ,  A61K31/4985 ,  A61K31/501 ,  A61K31/506 ,  A61K31/5383 ,  A61K31/541 ,  A61K31/542 ,  A61K31/551 ,  A61K31/553 ,  A61K31/695 ,  C07D417/04 ,  C07D417/14 ,  C07D491/048 ,  C07D491/10 ,  C07D498/04 ,  C07D513/04

摘要： (Wherein n is an integer of from 0 to 3; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, —COR8, or the like; R3 and R4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, —COR12, or the like)For example, provided are adenosine A2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.

摘要翻译： （其中n为0〜3的整数; R 1为取代或未取代的环烷基，取代或未取代的芳基，取代或未取代的脂环族杂环基或取代或未取代的芳香族杂环基; R2为卤素，取代或未取代的低级烷基 取代或未取代的芳基，取代或未取代的脂环族杂环基，取代或未取代的芳族杂环基，-COR 8等; R 3和R 4可以相同或不同，表示氢原子，取代或未取代的低级 烷基，取代或未取代的芳烷基，-COR 12等）例如，提供的是腺苷A 2A受体拮抗剂，其包含作为活性成分的由通式（I）表示的噻唑衍生物或其药学上可接受的盐，以及 类似。

公开(公告)号：US07718808B2

公开(公告)日：2010-05-18

申请号：US10584633

申请日：2004-12-24

申请人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

发明人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

IPC分类号： A61K31/427 ,  C07D417/14

CPC分类号： C07D417/06 ,  A61K31/427 ,  A61K31/438 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/454 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/497 ,  A61K31/4985 ,  A61K31/501 ,  A61K31/506 ,  A61K31/5383 ,  A61K31/541 ,  A61K31/542 ,  A61K31/551 ,  A61K31/553 ,  A61K31/695 ,  C07D417/04 ,  C07D417/14 ,  C07D491/048 ,  C07D491/10 ,  C07D498/04 ,  C07D513/04

摘要： (Wherein n is an integer of from 0 to 3; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, —COR8, or the like; R3 and R4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, —COR12, or the like)For example, provided are adenosine A2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.

摘要翻译： 本发明提供的腺苷A 2A受体拮抗剂包含作为活性成分的由通式（I）表示的噻唑衍生物或其药学上可接受的盐：......（其中n为0-3的整数; R 1为取代或 取代或未取代的芳基，取代或未取代的脂环族杂环基或取代或未取代的芳族杂环基; R2为卤素，取代或未取代的低级烷基，取代或未取代的芳基，取代或未取代的脂环族杂环基， 或未取代的芳族杂环基，-COR 8等; R 3和R 4可以相同或不同，各自表示氢原子，取代或未取代的低级烷基，取代或未取代的芳烷基，-COR 12等）。

公开(公告)号：US5360786A

公开(公告)日：1994-11-01

申请号：US100139

申请日：1993-08-02

申请人： Shoji Tanaka ,  Koichi Kitazawa ,  Shin-ichi Uchida ,  Hidenoir Takagi

发明人： Shoji Tanaka ,  Koichi Kitazawa ,  Shin-ichi Uchida ,  Hidenoir Takagi

IPC分类号： H01L39/12 ,  H01B1/00

CPC分类号： H01L39/126 ,  Y10S505/775 ,  Y10S505/776 ,  Y10S505/777 ,  Y10S505/778

摘要： The disclosed superconductive material has a characteristic in accordance with which electrical resistance disappears at a temperature of at least more than the boiling point of 20.3.degree. K. (-252.7.degree. C.) of liquid hydrogen and relates to La-Ba-Cu-O series superconductive material.Said superconductive material consists essentially of a composition having the formula(La.sub.1-x M.sub.x).sub.2 CuO.sub.4-x/2wherein, M=Ba or Ba(Sr, Ca) and x=0.04.about.0.20 as a main body, wherein the material has a K.sub.2 NiF.sub.4 crystal structure.

摘要翻译： 所公开的超导材料具有根据其电阻在至少大于液态氢的20.3°K（-252.7℃）的沸点的温度下消失的特性，并且涉及La-Ba-Cu-O 系列超导材料。 所述超导材料基本上由具有式（La1-xMx）2CuO4-x / 2的组合物组成，其中M = Ba或Ba（Sr，Ca）和x = 0.04 DIFFERENCE 0.20为主体，其中该材料具有K2NiF4 晶体结构。

公开(公告)号：US4871700A

公开(公告)日：1989-10-03

申请号：US193065

申请日：1988-05-12

申请人： Shin-ichi Uchida ,  Kozi Deguchi ,  Masamitsu Sasaki

发明人： Shin-ichi Uchida ,  Kozi Deguchi ,  Masamitsu Sasaki

IPC分类号： B01J38/16 ,  B01J23/88 ,  B01J23/94 ,  C07C45/35 ,  C07C45/37 ,  C07C47/22

CPC分类号： B01J23/94 ,  C07C45/35 ,  C07C45/37 ,  Y02P20/584

摘要： A method of reactivating a catalyst having reduced activity as a result of having been used in producing an unsaturated aldehyde as a main product by catalytic vapor-phase oxidation reaction of propylene, isobutylene or tertiary butanol, said catalyst being a catalytic oxide comprising molybdenum, bismuth and iron with a Mo:Fe atomic ratio of 12:at least 0.1. The method comprises heat-treating the used catalyst at a temperature of 300.degree. to 500.degree. C. in the presence of a flowing oxidizing gas containing at least 5% by volume of molecular oxygen and at least 0.1% by volume of steam.

公开(公告)号：US08420827B2

公开(公告)日：2013-04-16

申请号：US12960937

申请日：2010-12-06

申请人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

发明人： Takao Nakajima ,  Masamori Sugawara ,  Shin-ichi Uchida ,  Tetsuji Ohno ,  Yuji Nomoto ,  Noriaki Uesaka ,  Yoshisuke Nakasato

IPC分类号： A61K31/427 ,  C07D417/14

CPC分类号： C07D417/06 ,  A61K31/427 ,  A61K31/438 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/454 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/497 ,  A61K31/4985 ,  A61K31/501 ,  A61K31/506 ,  A61K31/5383 ,  A61K31/541 ,  A61K31/542 ,  A61K31/551 ,  A61K31/553 ,  A61K31/695 ,  C07D417/04 ,  C07D417/14 ,  C07D491/048 ,  C07D491/10 ,  C07D498/04 ,  C07D513/04

摘要： Wherein n is an integer of from 0 to 3; R1A is a 5-membered aromatic heterocyclic group containing at least one oxygen atom; R2A is —COR8 (wherein R8 is aryl); R3A is hydrogen or lower alkyl; and R12 represents cycloalkyl, aryl, aralkyl, alicyclic heterocyclic group, aromatic heterocyclic group, alicyclic hetocyclic-alkyl, or aromatic heterocyclic-alkyl, and R1A, R2A, R3A and R12 are individually optionally substituted.

摘要翻译： - 根据式（1A）的化合物，其中n为0至3的整数; R1A是含有至少一个氧原子的5元芳族杂环基; R2A是-COR8（其中R8是芳基）; R3A是氢或低级烷基; R 12表示环烷基，芳基，芳烷基，脂环族杂环基，芳香族杂环基，脂环族环状烷基或芳香族杂环烷基，R1A，R2A，R3A，R12分别任选被取代，及其药学上可接受的盐。